806 related articles for article (PubMed ID: 29202762)
1. Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.
Russell J; Du Toit EF; Peart JN; Patel HH; Headrick JP
Cardiovasc Diabetol; 2017 Dec; 16(1):155. PubMed ID: 29202762
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Hydrogen Sulfide Preconditioning-Associated Protection Against Ischemia-Reperfusion Injury Differs in Diabetic Heart That Develops Myopathy.
Ansari M; Kurian GA
Cardiovasc Toxicol; 2020 Apr; 20(2):155-167. PubMed ID: 31317389
[TBL] [Abstract][Full Text] [Related]
3. Sarcolemmal cholesterol and caveolin-3 dependence of cardiac function, ischemic tolerance, and opioidergic cardioprotection.
See Hoe LE; Schilling JM; Tarbit E; Kiessling CJ; Busija AR; Niesman IR; Du Toit E; Ashton KJ; Roth DM; Headrick JP; Patel HH; Peart JN
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(6):H895-903. PubMed ID: 25063791
[TBL] [Abstract][Full Text] [Related]
4. Chronic Co-Administration of Sepiapterin and L-Citrulline Ameliorates Diabetic Cardiomyopathy and Myocardial Ischemia/Reperfusion Injury in Obese Type 2 Diabetic Mice.
Baumgardt SL; Paterson M; Leucker TM; Fang J; Zhang DX; Bosnjak ZJ; Warltier DC; Kersten JR; Ge ZD
Circ Heart Fail; 2016 Jan; 9(1):e002424. PubMed ID: 26763290
[TBL] [Abstract][Full Text] [Related]
5. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
6. Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats.
Li H; Bian Y; Zhang N; Guo J; Wang C; Lau WB; Xiao C
Cardiovasc Diabetol; 2013 Jun; 12():91. PubMed ID: 23777472
[TBL] [Abstract][Full Text] [Related]
7. Cardioprotective effect of L-glutamate in obese type 2 diabetic Zucker fatty rats.
Povlsen JA; Løfgren B; Rasmussen LE; Nielsen JM; Nørregaard R; Kristiansen SB; Bøtker HE; Nielsen TT
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):892-8. PubMed ID: 19298538
[TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats.
Su W; Zhang Y; Zhang Q; Xu J; Zhan L; Zhu Q; Lian Q; Liu H; Xia ZY; Xia Z; Lei S
Cardiovasc Diabetol; 2016 Oct; 15(1):146. PubMed ID: 27733157
[TBL] [Abstract][Full Text] [Related]
9. Morphine induces physiological, structural, and molecular benefits in the diabetic myocardium.
Zemljic-Harpf AE; See Hoe LE; Schilling JM; Zuniga-Hertz JP; Nguyen A; Vaishnav YJ; Belza GJ; Budiono BP; Patel PM; Head BP; Dillmann WH; Mahata SK; Peart JN; Roth DM; Headrick JP; Patel HH
FASEB J; 2021 Mar; 35(3):e21407. PubMed ID: 33583084
[TBL] [Abstract][Full Text] [Related]
10. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus.
Lejay A; Fang F; John R; Van JA; Barr M; Thaveau F; Chakfe N; Geny B; Scholey JW
J Mol Cell Cardiol; 2016 Feb; 91():11-22. PubMed ID: 26718721
[TBL] [Abstract][Full Text] [Related]
11. Plasticity of sarcolemmal KATP channel surface expression: relevance during ischemia and ischemic preconditioning.
Yang HQ; Foster MN; Jana K; Ho J; Rindler MJ; Coetzee WA
Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1558-66. PubMed ID: 27037371
[TBL] [Abstract][Full Text] [Related]
12. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
Ferdinandy P; Schulz R; Baxter GF
Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
[TBL] [Abstract][Full Text] [Related]
13. Streptozotocin-induced type II diabetic rat administered with nonobesogenic high-fat diet is highly susceptible to myocardial ischemia-reperfusion injury: An insight into the function of mitochondria.
Ansari M; Gopalakrishnan S; Kurian GA
J Cell Physiol; 2019 Apr; 234(4):4104-4114. PubMed ID: 30191974
[TBL] [Abstract][Full Text] [Related]
14. The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy.
Duerr GD; Heinemann JC; Suchan G; Kolobara E; Wenzel D; Geisen C; Matthey M; Passe-Tietjen K; Mahmud W; Ghanem A; Tiemann K; Alferink J; Burgdorf S; Buchalla R; Zimmer A; Lutz B; Welz A; Fleischmann BK; Dewald O
Basic Res Cardiol; 2014 Jul; 109(4):425. PubMed ID: 24980781
[TBL] [Abstract][Full Text] [Related]
15. HMGB1: the missing link between diabetes mellitus and heart failure.
Volz HC; Seidel C; Laohachewin D; Kaya Z; Müller OJ; Pleger ST; Lasitschka F; Bianchi ME; Remppis A; Bierhaus A; Katus HA; Andrassy M
Basic Res Cardiol; 2010 Nov; 105(6):805-20. PubMed ID: 20703492
[TBL] [Abstract][Full Text] [Related]
16. Effect of diabetes on alteration of metabolism in cardiac myocytes: therapeutic implications.
Kota SK; Kota SK; Jammula S; Panda S; Modi KD
Diabetes Technol Ther; 2011 Nov; 13(11):1155-60. PubMed ID: 21751873
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of dynamin-related protein 1 protects against myocardial ischemia-reperfusion injury in diabetic mice.
Ding M; Dong Q; Liu Z; Liu Z; Qu Y; Li X; Huo C; Jia X; Fu F; Wang X
Cardiovasc Diabetol; 2017 Feb; 16(1):19. PubMed ID: 28173848
[TBL] [Abstract][Full Text] [Related]
18. The SAFE pathway for cardioprotection: is this a promising target?
Hadebe N; Cour M; Lecour S
Basic Res Cardiol; 2018 Jan; 113(2):9. PubMed ID: 29335904
[TBL] [Abstract][Full Text] [Related]
19. Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy.
Al Kury LT
J Diabetes Res; 2020; 2020():1942086. PubMed ID: 33274235
[TBL] [Abstract][Full Text] [Related]
20. Amylin and diabetic cardiomyopathy - amylin-induced sarcolemmal Ca
Liu M; Hoskins A; Verma N; Bers DM; Despa S; Despa F
Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt B):1923-1930. PubMed ID: 29066284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
